Comparing Terbinafine vs Clotrimazole Topical
| Terbinafine | Clotrimazole topical |
|
|---|
| Terbinafine | Clotrimazole topical |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Onychomycosis - Toenail, Tinea Capitis, Cutaneous Candidiasis, Onychomycosis - Fingernail, Tinea Corporis, Tinea Cruris, Tinea Pedis. Terbinafine may also be used for purposes not... View more |
Prescription and OTC
Prescribed for Tinea Corporis, Cutaneous Candidiasis, Balanoposthitis, Tinea Pedis, Paronychia, Tinea Versicolor, Vaginal Yeast Infection, Intertrigo, Tinea Cruris. Clotrimazole topical may also be... View more |
Related suggestions Tinea Corporis
Cutaneous Candidiasis
Tinea Pedis
Tinea Cruris
|
|||||||||||||||
| More about Terbinafine | More about Clotrimazole topical | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Terbinafine has an average rating of 6.3 out of 10 from a total of 493 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 32% reported a negative effect. |
Clotrimazole topical has an average rating of 8.4 out of 10 from a total of 32 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Terbinafine side effects |
View all Clotrimazole topical side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Terbinafine prices |
View all Clotrimazole topical prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Lamisil, Terbinex | Canesten, Canesten 1, Canesten 3, Canesten 6 Day Pessary, Clotrimazole-3, Clotrimazole-7, Desenex Antifungal Cream, Femcare, FungiCURE Pump Spray, Gyne-Lotrimin, Gyne-Lotrimin 3 Day, Lotrimin AF Athlete's Foot Cream, Lotrimin AF Jock Itch Cream, Lotrimin AF Ringworm Cream, Trivagizole 3 View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
200 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 156 drugs are known to interact with Terbinafine:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 10, 1996 |
February 03, 1975 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.